Clinical Trials Logo

Cancer of Endometrium clinical trials

View clinical trials related to Cancer of Endometrium.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05233059 Completed - Quality of Life Clinical Trials

FitEx for Endometrial Cancer Survivors

Start date: July 28, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether a physical activity tracking program called FitEx would be useful to endometrial cancer survivors. Each interested endometrial cancer survivor will recruit 1 to 5 additional friends/family members to participate in the intervention with them, forming a team. Each team will be randomized to FitExEC (control group) that receives FitEx for endometrial cancer survivors, or FitExEC+yoga (experimental group) that receives FitEx for endometrial cancer survivors plus yoga cueing. FitExEC is based on FitEx, a program used to encourage adults to improve their fruit and vegetable intake while increasing their physical activity. FitEx works by having participants join a team with their friends and loved ones, so they can support one another in meeting their goals. In this study, teams of endometrial cancer survivors/support members will receive watches that track how much they walk. Each day, participants record how much exercise, how many fruits, and how many vegetables they've eaten that day for a total of 8 weeks. Participants will be encouraged to attend a virtual session 15 minutes per week that will focus on 1-mile worth of exercise points (all control) or 15 minutes of yoga (all experimental) followed by 15 minutes of support (endometrial cancer survivors only [control and experimental survivors in different groups]). Participation in the study lasts roughly 10 weeks, and participants will be followed for 6 months afterward. The investigators think that FitEx may help people with endometrial cancer improve their daily physical activity and slowly improve their health and quality of life. The investigators hypothesize this intervention is feasible and acceptable to Carilion Clinic endometrial cancer survivors.

NCT ID: NCT04891146 Completed - Clinical trials for Cancer of Endometrium

The Effect of Anesthesia on Systemic Inflammatory Immune Index in Major Abdominal Cancer Surgeries

Start date: March 5, 2020
Phase:
Study type: Observational [Patient Registry]

The effects of different anesthesia methods on the immune system are variable. In this study, we investigated the effect of inhalation anesthesia and total intravenous anesthesia on the SII value in major abdominal cancer surgeries.

NCT ID: NCT02387645 Completed - Clinical trials for Endometrial Neoplasms

LUDEC Study - Pilot Study of the Lavage of the Uterine Cavity for the Diagnosis of Endometrial Carcinoma

LUDEC
Start date: May 2014
Phase: N/A
Study type: Interventional

The current pilot study aims at answering the scientific question, whether exfoliated cells from Endometrium Carcinoma (EC) can be detected in the lavage fluid from the uterine cavity and proximal fallopian tubes with the same sensitivity as in specimen from liquid-based cervical cytology. If this turns out to be the case, earlier detection, particularly of type II EC should be possible.

NCT ID: NCT00859768 Completed - Breast Cancer Clinical Trials

The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients

Start date: April 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effectiveness and feasibility of the Screening Inventory of Psychosocial Problems (SIPP) in consultation settings with respect to early recognition and treatment of psychosocial distress, communication between patients and physicians, and psychological distress and quality of life in cancer patients treated with radiotherapy (RT).

NCT ID: NCT00377520 Completed - Neoplasms Clinical Trials

A Trial for Patients With Advanced/Recurrent Endometrial Cancer

Start date: September 2006
Phase: Phase 2
Study type: Interventional

The intent of this protocol is to screen a new agent for activity in patients with advanced or recurrent endometrial carcinoma. This phase II trial is studying how well pemetrexed disodium works in treating patients with advanced or recurrent endometrial carcinoma.